Nucleic Acids On-Demand World-Wide (NOW)

The goal of the NOW program is to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to produce, formulate, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA) in less than 24 hours.

The developed platform

should be a resilient, mobile, readily accessible nucleic acid MCM manufacturing capability that enables immediate threat response anywhere the military operates with minimal user intervention.
Related Programs

Research and Technology Development

Department of Defense


Agency: Department Of Defense

Office: DARPA - Biological Technologies Office

Estimated Funding: $81,498


Who's Eligible


Relevant Nonprofit Program Categories



Obtain Full Opportunity Text:
FedBizOpps Announcement

Additional Information of Eligibility:
All responsible sources capable of satisfying the Government's needs may submit a proposal that shall be considered by DARPA.

See the Eligibility Information section of the BAA for more information.

Full Opportunity Web Address:
https://beta.sam.gov/opp/012d635117004012a37295c2b10ff78f/view

Contact:


Agency Email Description:
lstrong@usbr.gov

Agency Email:


Date Posted:
2019-10-16

Application Due Date:


Archive Date:
2020-02-08


In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.




Jobs in the Social Sector

  Substance Abuse Jobs
  Substance Abuse Jobs
  Social Work Jobs
  Social Services Employment
  Education Jobs





More Federal Domestic Assistance Programs


Environmental Management Indian  | Emerging Markets Program | Noninsured Assistance | Science, Technology, Business and/or Education Outreach | Impact Aid |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2021 Copyright Michael Saunders